Goodbody Health Ltd (AQSE:GDBY, OTCQB:GDBYF) group CEO George Thomas speaks to Proactive after launching a new platform that he describes as the "Uber for mobile phlebotomy." Thomas reveals more about the market opportunity for the new service, adding that it represents the "next step" into the blood testing market for the UK-based aggregator of health and wellness products and services. Contact Details Proactive UK Ltd +44... Read More

ST PETER PORT, GUERNSEY / ACCESSWIRE / January 31, 2023 / Goodbody Health Limited (AQSE:GDBY)(OTCQB:GDBYF) (" Goodbody " or the " Company "), is pleased to announce that it has made significant progress with extending its phlebotomy services. The Company has signed 4 phlebotomy contracts with other testing suppliers who wish to use Goodbody Clinics as a phlebotomy partner. These initial partners are: Rainbow Laboratories... Read More

ST PETER PORT, GUERNSEY / ACCESSWIRE / January 26, 2023 / Goodbody Health Limited (AQSE:GDBY) (OTCQB:GDBYF) ("Goodbody" or the "Company"), is pleased to announce that it has partnered with Datar Cancer Genetics ("Datar") a world-leading liquid biopsy company to offer its innovative Circulating Tumor Cell (CTC) based multi-cancer screening solution Trucheck in the UK. According to Dr Vineet Datta, Executive Director at Datar... Read More

ST PETER PORT, GUERNSEY / ACCESSWIRE / December 29, 2022 / Goodbody Health Limited (AQSE:GDBY)(OTCQB:GDBYF) (" Goodbody " or the " Company "), today announces the following Board updates. Geremy Thomas will be stepping down from his executive duties, effective 1st January 2023, but will remain as the Non-Executive Chairman of the Board. Anne Tew is also stepping down from the Board as a Director and from her role as Chief... Read More

ST PETER PORT, GUERNSEY / ACCESSWIRE / December 16, 2022 / Goodbody Health Limited (AQSE:GDBY)(OTCQB:GDBYF) (" Goodbody " or the " Company "), today announces that that it has agreed to sell the Polish CBD related elements of its operations to Voyager Life PLC ("Voyager") in return for a consideration of £1.5m, comprising £0.5m cash and £1.0m convertible loan notes ("CLNs"). The divestment comprises the share sale of the... Read More

ST PETER PORT, GUERNSEY / ACCESSWIRE / December 1, 2022 / Goodbody Health Limited (AQSE:GDBY)(OTCQB:GDBYF) (" Goodbody " or the " Company "), today announces that Marc Howells has resigned from the Board and as Chief Executive Officer, with immediate effect. The Company wishes to thank Marc for his contribution to the Company. George Thomas, an existing Executive Director of Goodbody Health and Managing Director of Goodbody... Read More

ST PETER PORT, GUERNSEY / ACCESSWIRE / November 10, 2022 / Goodbody Health Limited (AQSE:GDBY)(OTCQB:GDBYF) (" Goodbody " or the " Company "), today announces its Q3 2022 unaudited Interim Financial Statements for the nine months to 30 September 2022. The revenue at £9.29m was £0.59m lower than the comparative period in 2021. As anticipated, the Q3 quarter was lower than Q2 due to the expected decline in COVID testing due to... Read More

Goodbody Health Limited (AQSE:GDBY)(OTCQB:GDBYF) (" Goodbody " or the " Company "), today announces that it has signed an agreement with Allied Pharmacies Limited to join the Goodbody clinic network. The new Allied Pharmacies clinics adds 17 pharmacies that can provide a range of services including the range of diagnostic testing offered by the Goodbody clinics and other health services including ear wax micro suction.... Read More

Goodbody Health Limited (AQSE:GDBY)(OTCQB:GDBYF) (" Goodbody " or the " Company "), today announces that that it has signed a contract with Tasso Inc ("Tasso"), the leading provider of convenient, clinical grade blood collection solutions, for the UK pharmacy and wellness market. Tasso produces a signature line of virtually painless medical devices to draw a capillary blood sample with no needles and without the need for a... Read More

Goodbody Health Limited (AQSE:GDBY)(OTCQB:GDBYF) (" Goodbody " or the " Company "), today announces that Geremy Thomas, the Executive Chairman and Director of the Company transferred 200,000 ordinary shares to an unrelated party for nil consideration on August the 30th 2022. Post this transaction Geremy Thomas has an interest in 7,640,638 ordinary shares, representing approximately 20.94% of the issued share capital of the... Read More

Goodbody Health Limited (AQSE:GDBY) (OTCQB:GDBYF) (" Goodbody " or the " Company "), is pleased to confirm the completion of the Company's continuation to Guernsey, effective August 19th, 2022, as previously announced which changes the name from Goodbody Health Inc. to Goodbody Health Limited. Also as previously announced, the Company's voluntary delisting from the CSE occurred at the close of trading on August 17, 2022... Read More

Goodbody Health Inc. (OTCQB:GDBYF) (" Goodbody Health " or the " Company ") is pleased to announce its half year 2022 unaudited Interim Financial Statements for the six months to 30 June 2022. The revenue at C$12.22m ( £7.40m) was C$4.21m (£2.55m) higher than the comparative period in 2021. As anticipated, the quarter was lower than Q1 due to the expected decline in COVID testing. Non-Covid testing continues to be rolled out... Read More

Goodbody Health Inc. (CSE:GDBY) (OTCQB:GDBYF) (" Goodbody " or the " Company "), is pleased to announce the results of the Company's Annual General and Special Meeting of the shareholders held on August 09, 2022 (the "Meeting"). At the Meeting there were 77,050,554 shares represented in person or by proxy and voted, representing 21% of the total shares issued and outstanding. A majority of the shares were voted to accept the... Read More

Goodbody Health Inc. (CSE:GDBY) (OTCQB:GDBYF) (" Goodbody " or the " Company "), announces that further to its news release dated June 10, 2022, the Company has mailed its proxy materials, with instructions on how to attend and vote, to its shareholders of record as of July 5, 2022 for its annual general and special meeting to be held on August 9, 2022 at 9 am (Pacific time) at The Blue Building, Stubbs Lane, Beckington,... Read More

Goodbody Health Inc. (CSE:GDBY) (OTCQB:GDBYF) (" Goodbody Health " or the " Company ") is pleased to announce that it is launching new genetic cancer tests to help customers gauge and understand their cancer and heart disease risk better in conjunction with Everything Genetic. These tests provide medically validated genetic testing for cancer and heart disease allowing customers to take control of their health and to detect... Read More

Goodbody Health Inc. (CSE:GDBY)(OTCQB:GDBYF) (" Goodbody Health " or the " Company ") is pleased to announce that following its application for registration with the Care Quality Commission (CQC) last year, the Company has successfully passed the registration criteria and now provides all its testing services under the regulated activity diagnostic and screening procedures. CQC is the independent regulator of health and... Read More

Aligns With Company's Substantial U.K. Presence and Supports Its Growth Strategy Redomicile to Guernsey Goodbody Health Inc. (CSE:GDBY) (OTCQB:GDBYF) (" Goodbody " or the " Company "), today announced its intention to de-list from the Canadian Securities Exchange ("CSE") and to re-domicile the Company from the Province of British Columbia to Guernsey, subject to shareholder approval. This re-domiciliation is intended to... Read More

Goodbody Health Inc. (CSE:GDBY) (OTCQB:GDBYF) (" Goodbody Health " or the " Company ") is pleased to announce that, it has launched its core UK Health check which offers a comprehensive summary of a person's health. Keenly priced at £99, this new test includes innovative in-clinic diabetes and cholesterol tests, with results finalised in minutes. These tests determine a person's risk for developing cardiac health problems or... Read More

Goodbody Health Inc. (CSE:GDBY) (OTCQB:GDBYF) (" Goodbody Health " or the " Company ") is pleased to announce its highest comprehensive profit of £0.10m and adjusted EBITDA of £0.23m in its unaudited Interim Financial Statements for the three months to 31 March 2022. The revenue at £5.17m was also the second-best quarter to date after Q4 2021. The Company has filed the Financial Statements and Management's Discussion and... Read More

Goodbody Health Inc. (CSE:GDBY) (OTCQB:GDBYF) (" Goodbody Health " or the " Company ") is pleased to announce today a positive adjusted EBITDA of £0.48 million (C$0.83m) in its audited Financial Statements for the year to 31 December 2021. The Company has filed the Financial Statements and Management's Discussion and Analysis for year ending 2021 with strong results, especially in the second half of the year due to its... Read More

Goodbody Health Inc. (CSE:GDBY) (OTCQB:GDBYF) (" Goodbody Health " or the " Company ") is pleased to announce that its subsidiary, PhytoVista Laboratories, has been granted a controlled drugs licence that allows the company to handle up to Schedule 1 Controlled Drugs. This comes as the UK authorities look to the regulation of the UK consumer cannabinoid product testing infrastructure ahead of wider compliance within the... Read More

Goodbody Health Inc. (CSE:GDBY) (OTCQB:GDBYF) (" Goodbody Health " or the " Company ") is pleased to announce that, following the UK Food Standard Agencies (FSA) publication of the Novel Foods approved list for CBD, the Company's application has been approved by the FSA to the next stage of the Novel Foods submission, being the publication of the FSA CBD Products register. The status of 'Awaiting Evidence' means the FSA are... Read More

Goodbody Health Inc. (CSE:GDBY) (" Goodbody Health " or the " Company ") is pleased to announce a new sponsorship agreement with James Hedley for the Formula GB3 2022 Season. The Company Sponsored James in the 2019 Ginetta Junior Season following his win in the 2018 Ginetta Junior Winter Series Championship. He went on to become the 2019 Ginetta Junior Champion before moving onto Formula 4 in 2020 and 2021. In Formula 4, as... Read More

Sativa Wellness Group Inc. (CSE:SWEL) ("Sativa Wellness" or the "Company") is pleased to announce a change of name to Goodbody Health Inc to align the parent company with its main brand name "Goodbody" and its trading subsidiaries "Goodbody Wellness Limited" and "Goodbody Botanicals Ltd". After significant feedback, the Board decided that the Goodbody brand using the proposition "Know More-Live Better", better promotes and... Read More

Sativa Wellness Group Inc. (CSE:SWEL) (" Sativa Wellness " or the " Company ") announced today the successful achievement of ISO 22000 certification applicable to food safety relating to cannabis extraction at its Polish plant. The company also successfully passed the Hazard Analysis and Critical Control Point ("HACCP") requirements, including Good Hygiene Practice ("GHP") and Good Manufacturing Practice ("GMP") as one of... Read More

Sativa Wellness Group Inc. (CSE:SWEL) (" Sativa Wellness " or the " Company ") is pleased to announce that last week was the Company's best week to date for bookings, with several days exceeding previous records. This meant the company exceeded £13.8m revenue in the eleven months to the end of November. There are now over 140 clinics in the Goodbody network, including Superdrug supporting clinics. Goodbody clinics will... Read More

Sativa Wellness Group Inc. (CSE:SWEL) (" Sativa Wellness " or the " Company ") announced today that an application has been made to the Aquis Stock Exchange ("AQSE") and the Canadian Securities Exchange ("CSE") for 1,675,350 common shares of the Company ("Common Shares") to be admitted on or around 9 December 2021, subject to the approval of the CSE and AQSE. These are to be issued to a consultant who has exercised their... Read More

Sativa Wellness Group Inc. (CSE:SWEL) (" Sativa Wellness " or the " Company ") announced today that Sativa Wellness Group Inc ., (the Company ), has appointed Arden Partners Plc ("Arden") as the Company's AQSE Corporate Adviser and Broker. Geremy Thomas, Executive Chairman, said: "The appointment of Arden will further enable Sativa to achieve its significant aspirations in the health and wellness market. On previous... Read More

Sativa Wellness Group Inc. (CSE:SWEL) (" Sativa Wellness " or the " Company ") is pleased to announce that today it has partnered with Superdrug Stores Plc ("Superdrug") to offer an extensive range of blood tests. The agreement includes 40 Superdrug sites which have trained nurses to take blood for a range of tests including: Well Woman and Well Man Profiles Pre-Diabetes Cholesterol Organ Health, inc. Heart, Kidney and Liver... Read More

Sativa Wellness Group Inc. (CSE:SWEL) (OTC PINK:SCNNF) (" Sativa Wellness " or the " Company ") announced today a second quarterly profit in Q3 2021. The Company has filed the Financial Statements and Management's Discussion and Analysis for Q3 September 2021, demonstrating continued strong growth. All amounts unless stated otherwise are presented in British Pounds (GBP). The Company has continued to exceed all targets set... Read More

Sativa Wellness Group Inc. (CSE:SWEL) (OTC PINK:SCNNF) (" Sativa Wellness " or the " Company ") is pleased to announce that Monday this week saw the highest number of tests booked in a day exceeding 850 tests and C$180,000 (£100,000) of revenue. While the majority of tests are still COVID-19 tests for travelers, the proportion of blood tests being booked is growing consistently. The demand for PCR tests requested by the... Read More

Sativa Wellness Group Inc. (CSE:SWEL) (" Sativa Wellness " or the " Company ") is pleased to announce that it has launched the company's online telemedicine service ("the Virtual GP service") as it opens its 70th Goodbody clinic. The Virtual GP service gives all the Company's customers the opportunity to follow up their wellness test results with a virtual medical consultation. This contract with ‘The GP Service' is the next... Read More

Sativa Wellness Group Inc. (CSE:SWEL) (" Sativa Wellness " or the " Company ") is pleased to announce today that it has launched a full membership scheme through its website and new product range to include larger 30ml bottles. For members, 20% CBD Oil in 30ml bottles will be 20% cheaper and 20% stronger than the cheapest CBD on the market. The new price of a 30ml 20% CBD product will also offer members 50% more CBD or 50%... Read More

Sativa Wellness Group Inc. (CSE:SWEL)(OTC PINK:SCNNF) (" Sativa Wellness " or the " Company ") announced today that Sativa Wellness Group Inc ., formerly Stillcanna Inc., (the Company ), further to the completion of its recommended share-for-share exchange offer for Sativa Group plc which was implemented by means of a court-sanctioned scheme of arrangement under Part 26 of the Companies Act 2006, and which became effective... Read More

Sativa Wellness Group Inc. (CSE:SWEL) (" Sativa Wellness " or the " Company ") is pleased to announce today that it has signed a distribution agreement with German partners Lexamed GMBH ("Lexamed"). This exclusive agreement will allow both parties to work together to build the Goodbody CBD brand within Germany with plans to expand this to other European countries in the future. The German market has a strong CBD market, and... Read More

VANCOUVER, BC / ACCESSWIRE / August 12, 2021 / Sativa Wellness Group Inc. (CSE:SWEL) (" Sativa Wellness " or the " Company ") announced today its first quarterly profit for Q2 2021. The company has filed the Financial Statements and Management's Discussion and Analysis for Q2 June 2021 with exceptionally strong results which demonstrates the continued growth. The Company has exceeded all targets set to meet its ambition of... Read More

Sativa Wellness Group Inc. (CSE:SWEL) (" Sativa Wellness " or the " Company ") is pleased to announce its new business strategy following a strong start to the year. Highlights for first half of 2021 Change in leadership with the founder returning as Chair and a strong top team appointed. The Wellness business aligned in three clear divisions as CBD products, Cannabinoid testing and Clinic Testing Services each with a clear... Read More

Sativa Wellness Group Inc. (CSE:SWEL) ("Sativa Wellness" or the "Company") announces that Marc Howells, Chief Executive Officer, has been awarded 1,447,173 options over 1,447,173 Common Shares of the Company (“Director Options”). The Director Options vest immediately, have an exercise price of CS0.062 cents and are valid for 5 years. The exercise price of the Director Options, represents the closing mid-market price per... Read More

Sativa Wellness Group Inc. (CSE:SWEL)(OTC PINK:SCNNF) (" Sativa Wellness " or the " Company ") is pleased to announce that today the Company will open its 40 th clinic, and that it is also expected to list through Patient Access. Travel restrictions in the United Kingdom keep revenues flowing into the Company through the clinic network, as the clinics service the high level of demand for business travellers going to 'Amber... Read More

Sativa Wellness Group Inc. (CSE:SWEL) (" Sativa Wellness " or the " Company ") is pleased to announce that following its its collaboration with King's College London, investigating the potential therapeutic use of cannabinoids for the treatment of respiratory diseases, a research paper including the results of part of this research has been published. The primary purpose of this study was to investigate the anti-inflammatory... Read More

Sativa Wellness Group Inc. (CSE:SWEL) ("Sativa Wellness" or the "Company") announced today it has filed financial statements and management's discussion and analysis. All amounts unless stated otherwise are presented in British Pounds (GBP). The Company has maintained its presence within the CBD sector producing both quality isolate and distillate in Poland for the CBD market as well as continuing to produce a range of... Read More

Sativa Wellness Group Inc. (CSE:SWEL) (OTC PINK:SCNNF) ("Sativa Wellness" or the "Company") announced today it has filed amended and restated financial statements for the three and nine months ended September 30, 2020 (together with an amended corresponding management's discussion and analysis) (collectively, the "Amended Financials") in order to reflect the correct adjustments related to the share exchange arrangement on... Read More

Sativa Wellness Group Inc. (CSE:SWEL) (" Sativa Wellness " or the " Company ") wishes to announce the publication of its Financial Statements and Management, Discussion and Analysis report for year ended December 31, 2020. The key highlights of 2020 can be summarised as follows: 2020 Financial Results The turnover for 2020 was £1,994K (C$3,478K) which was a 38% increase on the previous year (£1,449K) and the gross profit... Read More

Sativa Wellness Group Inc. (CSE:SWEL) (" Sativa Wellness " or the " Company ") is pleased to announce the appointment of Marc Howells as Director and Chief Executive Officer and Anne Tew as Director and Chief Financial Officer of the Company. The Company wishes to thank both Geremy Thomas for his role as the interim CEO and Joseph Colliver as CFO for their respective contributions. Geremy Thomas will continue in his role as... Read More

Sativa Wellness Group Inc. (CSE:SWEL) (" Sativa Wellness " or the " Company ") wishes to announce that the Company's subsidiary, PhytoVista Laboratories, has been granted accreditation to ISO/IEC 17025:2017 - General requirements for the competence of testing and calibration laboratories. Accreditation for the testing of cannabinoids, has been granted by United Kingdom Accreditation Service (UKAS), the UK governments... Read More

Sativa Wellness Group Inc. (CSE:SWEL) (OTC PINK:SCNNF) (FSE:484) (AQSE:SWEL) (" Sativa Wellness " or the " Company ") is pleased to announce that it is now listed on the United Kingdom (the " UK ") government website to offer 2 and 8 day quarantine tests (the " Return Tests ") for travellers returning to the UK. The Return Tests are a significant addition to the Company's current offering of COVID-19 tests for travellers... Read More

VANCOUVER, BC / ACCESSWIRE / March 10, 2021 / Sativa Wellness Group Inc. (CSE:SWEL) (OTC PINK:SCNNF) (FSE:484) (AQSE:SWEL) (" Sativa Wellness " or the " Company ") is pleased to announce that its COVID testing clinic business has achieved CAD$2,000,000 of bookings (£1,140,000). This milestone has been achieved in less than 4 months from the first clinic being opened in Bath, UK. Since then, as well as the second company... Read More

Sativa Wellness Group Inc. (CSE:SWEL) (OTC PINK:SCNNF) (FSE:484) (AQSE:SWEL) (" Sativa Wellness " or the " Company "). Sativa Wellness is pleased to announce that its Polish extraction facility has secured accreditation of its Hazard Analysis and Critical Control Point (" HACCP ") system from global quality and certification company LL-C Group, and confirmation that its operations meet the requirements of Good Manufacturing... Read More

Sativa Wellness Group Inc. (CSE:SWEL) ("Sativa Wellness" or the "Company") announces that it intends to complete a non-brokered private placement financing (the "Financing") of units (each, a "Unit") for gross proceeds of up to CDN$4,000,000 with a price per Unit of CDN$0.07875. Each Unit will consist of one common share (each, a "Share") and one half of one common share purchase warrant (each, a "Warrant"), with each... Read More

Sativa Wellness Group Inc. (CSE:SWEL) (" Sativa Wellness " or the " Company ") Sativa Wellness is pleased to announce that our UK Bath and Bristol Goodbody clinics booked up to C$46K (£27K) a day in COVID testing revenues in December. Having proved the testing model in Bath and Bristol, we have rolled out a number of in-pharmacy clinics and today we open our tenth testing facility with a further twenty in-pharmacy clinics in... Read More

Sativa Wellness Group Inc. (CSE:SWEL) (" Sativa Wellness " or the " Company ") wishes to announce that it has submitted its Novel Food application for validation by the Food Standards Agency ("FSA") ahead of the 31 March 2021 deadline, as part of the Company's ongoing commitment to continually deliver the highest level of regulatory compliance and product quality - 'CBD you can trust'. The submission, led by award winning... Read More

Sativa Wellness Group Inc. (CSE:SWEL) (" Sativa Wellness " or the " Company ") is pleased to announce changes in the board of directors of the Company (the " Board "), who will be responsible for setting the strategic direction of the Company for the coming year. Further to the Company's news release dated January 29, 2021 regarding the Annual General and Special Meeting of the shareholders held on January 26, 2021 (the... Read More

Sativa Wellness Group Inc. (CSE:SWEL) ("Sativa Wellness" or the "Company") is pleased to announce the results of the Company's Annual General, and Special Meeting of the shareholders held on January 26, 2021 (the "Meeting"). There were 97,361,247 shares voted, representing 32.18% of the total shares issued and outstanding. A majority of the shareholders voted to accept the financial statements for each of the 2019 and 2020... Read More

Sativa Wellness Group Inc. (CSE:SWEL) (" Sativa Wellness " or the " Company ") wishes to announce the corporate highlights for 2020 and provide plans for 2021. 2020 Highlights Completed the reverse takeover of StillCanna Inc. (the "StillCanna Acquisition") in the third quarter of the calendar year, creating a vertically integrated European seed to consumer cannabidiol ("CBD") company. The StillCanna Acquisition added a CBD... Read More